BioMed Research International

Research Article

Synergistic Effect between Cisplatin and Sunitinib Malate on Human Urinary Bladder-Cancer Cell Lines

Table 3

Sub- -fraction of HT1376, T24, and 5637 urinary bladder-cancer cell lines, after treatment with cisplatin and sunitinib malate, in isolation or combined. Sub- values are mean ± SD of the three independent experiments.
 Sub- -fraction
 HT1376T245637
Control
Cisplatin (3  M)
Sunitinib malate (1  M)
Sunitinib malate (2  M)
Sunitinib malate (4  M)
Cisplatin (3  M) + sunitinib malate (1  M)
Cisplatin (3  M) + sunitinib malate (2  M)
Cisplatin (3  M) + sunitinib malate (4  M)
SD: standard deviation.